EZH2i EPZ-6438 and HDACi vorinostat synergize with ONC201/TIC10 to activate integrated stress response, DR5, reduce H3K27 methylation, ClpX and promote apoptosis of multiple tumor types including DIPG

This publication has 30 references indexed in Scilit:

• The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent
  Biochemical and Biophysical Research Communications, 2016
• ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases
  Science Signaling, 2016
• The interplay of histone modifications – writers that read
  EMBO Reports, 2015
• ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells
  Cell Cycle, 2015
• Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
  Molecular Cancer Therapeutics, 2014
• The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
  Genes & Development, 2013
• Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
  Science Translational Medicine, 2013
• The Polycomb complex PRC2 and its mark in life
  Nature, 2011
• Coupling of Endoplasmic Reticulum Stress to CDDO-Me–Induced Up-regulation of Death Receptor 5 via a CHOP–Dependent Mechanism Involving JNK Activation
  Cancer Research, 2008
• The polycomb group protein EZH2 is involved in progression of prostate cancer
  Nature, 2002